Eric W. Refsland

2.9k total citations · 1 hit paper
13 papers, 1.7k citations indexed

About

Eric W. Refsland is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Eric W. Refsland has authored 13 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Virology, 5 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Eric W. Refsland's work include HIV Research and Treatment (8 papers), Cytomegalovirus and herpesvirus research (4 papers) and HIV/AIDS drug development and treatment (4 papers). Eric W. Refsland is often cited by papers focused on HIV Research and Treatment (8 papers), Cytomegalovirus and herpesvirus research (4 papers) and HIV/AIDS drug development and treatment (4 papers). Eric W. Refsland collaborates with scholars based in United States and China. Eric W. Refsland's co-authors include Reuben S. Harris, William L. Brown, Lela Lackey, Judd F. Hultquist, Keisuke Shindo, Mark D. Stenglein, John S. Albin, Emily K. Law, Joy Lengyel and Rebecca S. LaRue and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Eric W. Refsland

12 papers receiving 1.7k citations

Hit Papers

APOBEC3B is an enzymatic source of mutation in breast cancer 2013 2026 2017 2021 2013 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. APOBEC3B is an enzymatic source of mutation in breast cancer
    2013 639 citations Michael B. Burns, Lela Lackey et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric W. Refsland United States 9 963 707 424 394 348 13 1.7k
Lela Lackey United States 14 1.1k 1.2× 452 0.6× 329 0.8× 199 0.5× 250 0.7× 21 1.6k
Rebecca S. LaRue United States 18 711 0.7× 797 1.1× 517 1.2× 464 1.2× 529 1.5× 30 1.7k
Emily K. Law United States 16 1.2k 1.3× 408 0.6× 333 0.8× 171 0.4× 255 0.7× 20 1.7k
Koen Bartholomeeusen Belgium 22 1.1k 1.2× 559 0.8× 160 0.4× 676 1.7× 287 0.8× 35 2.0k
Keisuke Shindo Japan 19 891 0.9× 1.1k 1.5× 532 1.3× 641 1.6× 459 1.3× 35 1.8k
Baek Kim United Kingdom 11 323 0.3× 459 0.6× 198 0.5× 193 0.5× 368 1.1× 30 984
Michelle J. West United Kingdom 21 793 0.8× 426 0.6× 324 0.8× 244 0.6× 419 1.2× 41 1.7k
Chiara Chiozzini Italy 18 728 0.8× 213 0.3× 249 0.6× 293 0.7× 334 1.0× 40 1.3k
Annie Yang United States 14 462 0.5× 461 0.7× 278 0.7× 134 0.3× 655 1.9× 40 1.3k
Yuanfei Wu United States 14 584 0.6× 595 0.8× 339 0.8× 276 0.7× 350 1.0× 19 1.3k

Countries citing papers authored by Eric W. Refsland

Since Specialization
Citations

This map shows the geographic impact of Eric W. Refsland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric W. Refsland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric W. Refsland more than expected).

Fields of papers citing papers by Eric W. Refsland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric W. Refsland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric W. Refsland. The network helps show where Eric W. Refsland may publish in the future.

Co-authorship network of co-authors of Eric W. Refsland

This figure shows the co-authorship network connecting the top 25 collaborators of Eric W. Refsland. A scholar is included among the top collaborators of Eric W. Refsland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric W. Refsland. Eric W. Refsland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gordon, Christopher J., et al.. (2025). Leveraging Implementation Science to End the HIV Epidemic in the United States: Progress and Opportunities for Federal Agencies. JAIDS Journal of Acquired Immune Deficiency Syndromes. 98(5S). e10–e16.
2.
Greenberg, Alan E., Anthony K. Wutoh, Lisa Bowleg, et al.. (2023). Supplemental Issue of the Journal of the Acquired Immune Deficiency Syndromes (JAIDS): The Centers for AIDS Research (CFAR) Diversity, Equity, and Inclusion Pathway Initiative (CDEIPI). JAIDS Journal of Acquired Immune Deficiency Syndromes. 94(2S). S1–S4. 1 indexed citations
3.
Blažková, Jana, Eric W. Refsland, Katherine E. Clarridge, et al.. (2019). Glycan-dependent HIV-specific neutralizing antibodies bind to cells of uninfected individuals. Journal of Clinical Investigation. 129(11). 4832–4837. 8 indexed citations
4.
Clarridge, Katherine E., Jana Blažková, Kevin Einkauf, et al.. (2018). Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals. PLoS Pathogens. 14(1). e1006792–e1006792. 66 indexed citations
5.
Refsland, Eric W., Judd F. Hultquist, Elizabeth M. Luengas, et al.. (2014). Natural Polymorphisms in Human APOBEC3H and HIV-1 Vif Combine in Primary T Lymphocytes to Affect Viral G-to-A Mutation Levels and Infectivity. PLoS Genetics. 10(11). e1004761–e1004761. 82 indexed citations
6.
Burns, Michael B., Lela Lackey, Michael A. Carpenter, et al.. (2013). APOBEC3B is an enzymatic source of mutation in breast cancer. Nature. 494(7437). 366–370. 639 indexed citations breakdown →
7.
Burns, Michael B., Lela Lackey, Michael A. Carpenter, et al.. (2013). Correction: Corrigendum: APOBEC3B is an enzymatic source of mutation in breast cancer. Nature. 502(7472). 580–580. 2 indexed citations
8.
Refsland, Eric W. & Reuben S. Harris. (2013). The APOBEC3 Family of Retroelement Restriction Factors. Current topics in microbiology and immunology. 371. 1–27. 167 indexed citations
9.
Refsland, Eric W., Judd F. Hultquist, & Reuben S. Harris. (2012). Endogenous Origins of HIV-1 G-to-A Hypermutation and Restriction in the Nonpermissive T Cell Line CEM2n. PLoS Pathogens. 8(7). e1002800–e1002800. 85 indexed citations
10.
Hultquist, Judd F., Joy Lengyel, Eric W. Refsland, et al.. (2011). Human and Rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H Demonstrate a Conserved Capacity To Restrict Vif-Deficient HIV-1. Journal of Virology. 85(21). 11220–11234. 280 indexed citations
11.
Jong, Ebbing P. de, Hongwei Xie, Getiria Onsongo, et al.. (2010). Quantitative Proteomics Reveals Myosin and Actin as Promising Saliva Biomarkers for Distinguishing Pre-Malignant and Malignant Oral Lesions. PLoS ONE. 5(6). e11148–e11148. 84 indexed citations
12.
Refsland, Eric W., Mark D. Stenglein, Keisuke Shindo, et al.. (2010). Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Research. 38(13). 4274–4284. 293 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lela Lackey Breakdown of academic impact, for papers by Rebecca S. LaRue Breakdown of academic impact, for papers by Emily K. Law Breakdown of academic impact, for papers by Koen Bartholomeeusen Breakdown of academic impact, for papers by Keisuke Shindo Breakdown of academic impact, for papers by Baek Kim Breakdown of academic impact, for papers by Michelle J. West Breakdown of academic impact, for papers by Chiara Chiozzini Breakdown of academic impact, for papers by Annie Yang Breakdown of academic impact, for papers by Yuanfei Wu
Rankless by CCL
2026